Guwahati, Oct 24: Probiotic products from Northeast will now offer natural solutions to lifestyle diseases such as lifestyle diseases such as diabetes and obesity.

The Institute of Advanced Study in Science and Technology (IASST), Guwahati, an autonomous institution under the Department of Science and Technology (DST), has entered into a significant research and development collaboration with Bharat Biotech International (BBIL).

The focus of this partnership is to bring innovative health products to market, derived from probiotics isolated from traditional fermented foods of Northeast India. These probiotics, studied extensively by IASST, show great promise in combating metabolic diseases, enhancing gut health, and promoting healthy ageing.

Professor Abhay Karandikar, Secretary of the Department of Science and Technology, emphasized the importance of this collaboration for Northeast India’s bioeconomy. He pointed out that the region’s rich biodiversity, especially its wealth of traditional fermented foods, plays a crucial role in this initiative. “This agreement is a milestone for IASST, aligning with the broader vision of promoting the region’s bioeconomy through scientific innovation,” he said during the signing ceremony.

The partnership between IASST and Bharat Biotech aims to commercialize innovative probiotic technologies developed by IASST. Bharat Biotech, renowned globally for its excellence in biopharmaceuticals and vaccines, will support the translation of these scientific discoveries into market-ready products. Pre-clinical and clinical studies will be conducted to ensure that these probiotics meet the necessary regulatory standards and demonstrate efficacy in addressing metabolic diseases.

Prof. Ashis Mukherjee, Director of IASST, underscored the importance of converting academic research into commercially viable products. He noted that this collaboration provides a unique opportunity for IASST to showcase Northeast India’s scientific potential on a global scale. Bharat Biotech’s involvement will be pivotal in ensuring that the products meet international health standards, while IASST will continue leading the research.

The agreement, signed by Prof. Mukherjee, Dr. Krishna Ella, Executive Chairman of BBIL, and Dr. Yogeshwar Rao from BBIL, outlines the roles of both parties. IASST will contribute its scientific expertise, and Bharat Biotech will oversee the commercialization of the products. A monitoring committee will ensure that the project progresses according to schedule, and IASST will receive royalties from the sales of these probiotic products.

Both IASST and Bharat Biotech expressed confidence in the partnership, envisioning that the innovations from this collaboration will not only boost the biotechnology sector but also have a global impact on health and wellness.

Read: NEHU to offer Korean language course from 2025; Khasi & Hindi to be taught in Korean institutions

WATCH: 

Find latest news from every corner of Northeast India at hubnetwork.in, your online source for breaking news, video coverage.

Also, Follow us on-

Twitter-twitter.com/nemediahub

Youtube channel- www.youtube.com/@NortheastMediaHub2020

Instagram- www.instagram.com/ne_media_hub

Download our app from playstore – Northeast Media Hub